1
Enquiry period
with 11.03.2019 15:31
to 18.03.2019 16:00
2
Bidding period
with 18.03.2019 16:00
to 21.03.2019 16:00
3
Auction
22.03.2019 11:55
4
Evaluation
5
Bids have been evaluated
Status Bids have been evaluated
Estimated value without VAT 264 MDL
Period of clarifications: 11 Mar 2019, 15:31 - 18 Mar 2019, 16:00
Submission of proposals: 18 Mar 2019, 16:00 - 21 Mar 2019, 16:00
Auction start date: 22 Mar 2019, 11:55

Supplier technical support:

(+373) 79999801

Vinpocetinum
Information about customer
Fiscal code/IDNO
Address
MD-2038, MOLDOVA, mun.Chişinău, mun.Chişinău, str. Zelinski,15
Web site
---
The contact person
Full name
E. Mucuta spbconstructorul
Contact phone
022639190
Purchase data
Date created
11 Mar 2019, 14:44
Date modified
11 Mar 2019, 15:31
Estimated value (without VAT)
264 MDL
The minimum downward of the price
2,64 MDL
Achizitii.md ID
21006081
Type of procedure
Procedură de valoare mică (goods)
Award criteria
The lowest price
Delivery address
MD-2038, MOLDOVA, mun.Chişinău, mun.Chişinău, str. Zelinski,15
Contract period
25 Mar 2019 02:00 - 29 Dec 2019 15:29
List of positions
1)
Title
Vinpocetinum CPV: 33600000-6 - Pharmaceutical products
Quantity: 200.0
Unit of measurement: Bucata
Documents of the procurement procedure

The offers of the participants are available below, you can view the documents for the offers by clicking on the folder icon.

Based on the Working Group Decision, the selection of a winner requires:

1) Choose winner by clicking the button "Winner.”

2) Отправить в течении 3 дней на почту AAP bap@tender.gov.md отсканированное решение рабочей группы.

4) After choosing the winner, press the button: "Confirm"..

Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

Farmacia Cojusna

Normalized price: 292,59 MDL
Status: Winner
Reason: conform cerintelor
Qualification documents
Documents folder missing
Documents provided with the proposal
The history of the auction
View auction
Unfortunately, questions can be asked only during the "Active" period.
Clarifications